More from Stocks
The setup on the weekly for the iShares 20+ Year Treasury Bond exchange-traded fund is a thing of beauty.
Let's sort out the FOMC meeting, what bonds are telling us and how this could all play out.
We will soon see if another V-shape move is in the cards.
In a market with elevated valuations and low yields, we see pharmaceutical stocks as a respite from both.